Lyophilized platelets: Challenges and opportunities

Journal of Trauma - Injury, Infection and Critical Care

Volumn 70, Issue 5 SUPPL., 2011, Pages

  Cap, Andrew P ^a   Perkins, Jeremy G ^b  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENVALERATE; FREEZE DRIED PLATELET; PADGEM PROTEIN; THROMBIN; THROMBOCYTE CONCENTRATE; THROMBOXANE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLEEDING TIME; COMPARATIVE STUDY; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE TRANSFUSION; THROMBOSIS;

ANIMALS; BLOOD COAGULATION DISORDERS; HUMANS; PLATELET TRANSFUSION; RESUSCITATION; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 79955852870     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31821a606d     Document Type: Article

References (15)

1. Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med. 2008;359:1261-1270.
2. Lee DH, Blajchman MA. Novel treatment modalities: new platelet preparations and substitutes. Br J Haematol. 2001;114:496-505. (Pubitemid 32953626)
3. Arnold P, Djerassi I, Farber S, Freeman G, Klein E, Toch R. The preparation and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia. J Pediatr. 1956;49: 517-522.
4. Stefanini M, Kistner SA. Platelets, platelet factors and platelet substitutes in the management of thrombocytopenic states. Bibl Haematol. 1958;7:378-381.
5. Fliedner TM, Sorensen DK, Bond VP, Cronkite EP, Jackson DP, Adamik E. Comparative effectiveness of fresh and lyophilized platelets in controlling irradiation hemorrhage in the rat. Proc Soc Exp Biol Med. 1958;99:731-733.
6. Jackson DP, Sorensen DK, Cronkite EP, Bond VP, Fliedner TM. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest. 1959;38:1689-1697.
7. Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA. 1995;92:397-401.
8. Fischer TH, Bode AP, Parker BR, et al. Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets. Transfusion. 2006;46:1943-1950. (Pubitemid 44631602)
9. Bode A, Blajchman MA, Bardossy L, et al. Hemostatic properties of human lyophilized platelets in a thrombocytopenic rabbit model. Blood. 1994;84(Suppl 1):464a.
10. Bode AP, Lust RM, Read MS, Fischer TH. Correction of the bleeding time with lyophilized platelet infusions in dogs on cardiopulmonary bypass. Clin Appl Thromb Hemost. 2008;14:38-54.
11. Fischer TH, Merricks E, Raymer R, et al. The co-infusion of rehydrated lyopholized platelets wth HBOC-201 for hemostasis in dilutional thrombocytopenia. Blood. 2001;98:2250.
12. Hawksworth JS, Elster EA, Fryer D, et al. Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine. J Thromb Haemost. 2009;7:1663-1671.
13. Valeri CR, MacGregor H, Barnard MR, Summaria L, Michelson AD, Ragno G. In vitro testing of fresh and lyophilized reconstituted human and baboon platelets. Transfusion. 2004;44:1505-1512. (Pubitemid 39318987)
14. Valeri CR, MacGregor H, Barnard MR, Summaria L, Michelson AD, Ragno G. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sang. 2005;88:122-129. (Pubitemid 40362928)
15. Fischer TH, Merricks E, Bellinger DA, et al. Splenic clearance mechanisms of rehydrated, lyophilized platelets. Artif Cells Blood Substit Immobil Biotechnol. 2001;29:439-451. (Pubitemid 34037688)